Search results
Why AbbVie (ABBV) is a Top Value Stock for the Long-Term
Zacks via Yahoo Finance· 1 day agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
US pharma giant Cencora says Americans' health information stolen in data breach
TechCrunch· 10 hours agoU.S. pharmaceutical giant Cencora says it is notifying affected individuals that their personal and...
Kristin Chenoweth Says 'It's Wonderful to Find Your Person' After Marrying Josh Bryant: 'I Waited...
OK! Magazine· 3 days agoShe finally got that ring!
AbbVie Completes Acquisition of Landos Biopharma
Valley City Times Record· 1 day agoWith the completion of the acquisition, Landos is now part of AbbVie. Landos' lead investigational asset is NX-13, a first-in-class, oral NLRX1 agonist (a member of the NOD-like ...
AbbVie Files Notice of Data Breach Impacting the Health Information of Tens of Thousands of...
JD Supra· 2 days agoOn May 22, 2024, AbbVie, Inc. filed a notice of data breach with the Attorney General of Texas after discovering that confidential information that had been entrusted to the ...
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information...
Benzinga via AOL· 6 hours agoU.S. drug wholesaler Cencora Inc (NYSE:COR), formerly AmerisourceBergen, is notifying affected...
1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165?
Motley Fool via Yahoo Finance· 4 days agoWall Street is feeling pretty good about AbbVie's (NYSE: ABBV) performance in 2024 so far. Louise...
This Is What Whales Are Betting On AbbVie - AbbVie (NYSE:ABBV)
Benzinga· 2 days agoLoading... Loading... Investors with a lot of money to spend have taken a bullish stance on AbbVie ABBV . And retail traders should know. We noticed this today when the positions ...
2 Billion More Reasons to Buy AbbVie Stock
Motley Fool via Yahoo Finance· 3 days agoThere are plenty of reasons to buy a leading biopharma business like AbbVie (NYSE: ABBV), and investors just got at least a few more. Thanks to a large...
AbbVie (NYSE:ABBV) Now Covered by Cantor Fitzgerald
ETF DAILY NEWS· 6 days agoCantor Fitzgerald assumed coverage on shares of AbbVie (NYSE:ABBV – Get Free Report) in a research note issued to investors on Friday, MarketBeat.com reports. Cantor Fitzgerald ...
